REFERENCES
- Feller WF, Chopra HC: Virus-like particles in human milk. Cancer 28: 1425–1430, 1971
- Dmochowski L: Viruses and breast cancer. Hosp Pract 7: 73–81, Jan 1972
- Moore DH, Charney J, Kramarsky B, et al: Search for a human breast cancer virus. Nature (Lond) 229: 611–614, 1971
- MacDonald D, O'Driscoll K: Suppression of lactation. A double-blind trial. Lancet 2: 623, 1965
- Gillibrand PN, Huntingford PJ: Inhibition of lactation with combined oestrogen and progestogen. Br Med J 4: 769, 1968
- Turnbull AC: Puerperal thrombo-embolism and suppression of lactation. J Obstet Gynaecol Br Commonw 75: 1321–1323, 1968
- McGlone J: An assessment of quinestrol in the inhibition of lactation. Practitioner 203: 187–188, 1969
- Watson PS: “Instant” inhibition of lactation. Practitioner 203: 184–186, 1969
- Cruttenden LA: Inhibition of lactation. Practitioner 206: 248, 1971
- Mann CW: Lactation inhibition in the Outer Hebrides. Practitioner 206: 246–247, 1971
- Lo Presto B, Caypinar EY: Prevention of postpartum lactation by administration of Deladumone during labor. JAMA 169: 250–252, 1959
- Watrous JB, Ahearn RE, Carvalho MA: Lactation inhibition by Deladumone injected during labor or just after delivery. JAMA 169: 246–249, 1959
- Bare WW, Zaleznik E, Levin H: Double-blind evaluation of two androgen-estrogen preparations and a placebo for suppression of lactation. Am J Obstet Gynecol 87: 276–279, 1963
- Kantor HI, Leib L, Kamholz JH: A new formulation with dual purpose: To inhibit lactation or to permit nursing. Am J Obstet Gynecol 85: 865–869, 1963
- Cole BW, Pitts NE: Suppression of lactation by a single injection of an androgen-oestrogen combination. Practitioner 196: 139–143, 1966
- Morris JA, Creasy RK, Hohe PT: Inhibition of puerperal lactation. Obstet Gynecol 36: 107–114, 1970
- Greenwald P, Barlow JJ, Nasca PC, et al: Vaginal cancer after maternal treatment with synthetic estrogens. N Engl J Med 285: 390–392, 1971
- Herbst AL, Ulfelder H, Poskanzer DC: Adenocarcinoma of the vagina. N Engl J Med 284: 878–881, 1971
- Folkman J: Transplacental carcinogenesis by stilbestrol. N Engl J Med 285: 404–405, 1971
- Malarkey WB, Jacobs LS, Daughaday WH: Levodopa suppression of prolactin in nonpuerperal galactorrhea. N Engl J Med 285: 1160–1163, 1971
- Lu KH, Koch Y, Meites J: Direct inhibition by ergocornine of pituitary prolactin release. Endocrinology 89: 229–233, 1971
- McDevitt E, Smith B: Thrombophlebitis during pregnancy and the puerperium. In Sherry S, Brinkhous KM, Genton E, et al (Editors): Thrombosis. Washington, DC, National Academy of Sciences-National Research Council, 1969, pp 55–66
- Hume M, Sevitt S, Thomas DP: Venous Thrombosis and Pulmonary Embolism. Cambridge, Mass, Harvard University Press, 1970, pp 54–84
- Turnbull AC, Daniel DG, McGarry JM: Antenatal and postnatal thrombo-embolism. Practitioner 206: 727–735, 1971
- Tindall VR: Factors influencing puerperal thromboembolism. J Obstet Gynaecol Br Commonw 75: 1324–1327, 1968
- Hill H: Oral contraception. Practitioner 205: 5–12, 1970
- Vorherr H: Unpublished observations
- Miyamoto J, Gomez L, Gold JJ: Effect of MRL-41 on postpartum breast manifestations. Am J Obstet Gynecol 85: 870–872, 1963